Abzena takes modular approach to biologics suites

This expansion has been driven by an increase in customer demand for commercial-scale 2000L single-use bioreactors across a wide range of therapeutic areas

picture of

Breaking News

Samsung Bioepis opens Korea HQ for biologics

The building was completed in December 2020

Thermo Fisher acquires viral vector manufacturing business from Novasep

The business will be part of the pharma services business within the laboratory products and services segment

Nanoform and Herantis partner

The companies will look for opportunities to enhance BBB penetration of CDNF and xCDNF molecules

Space travel puts mitochondria’s central role in the spotlight

The scientific community has long validated the significance of mitochondria as our cell’s “energy factories.” ...

WHP completes viral vector manufacturing centre for Oxford Biomedica

The centre is being used for the worldwide manufacture and distribution of the COVID-19 vaccine by AstraZeneca

EVerZom raises $1.3m to industrialise exosome biomanufacturing platform

This funding will speed up the platform development and scale-up, with the objective to allow routine clinical grade ...

The increasing power of single-cell omics: changing the future of medicine

Advances in the single-cell genomic analysis of cells and tissues, including the required computational methods, have ...

Watson-Marlow to open ISO 14644-1 Class 7 cleanroom

The facility at the site in Cork is currently in development and will be validated to ISO 9001 Quality Management ...

Thermo Fisher Scientific and Innoforce join forces

The two companies have partnered to establish a biologics and sterile drug manufacturing facility in China

Expanding the medicinal chemist’s toolbox

Ray Boffey, Executive Director of Medicines Research at Domainex, explains the applications and benefits of fragment- ...

Immunotherapy: antibody drug conjugates from a small molecule perspective

Immunotherapies such as ADCs deliver a more targeted treatment against cancer that improves the quality of life for the ...

The business and patient case for drug delivery device innovation in biosimilar products

Biosimilar development in the United States is at an important juncture, reports Darren Mansell, Regulatory Affairs ...

VMIC chooses BES to help with fast-tracked vaccine facility

Boulting has been chosen to fit out a new facility for the not for profit organisation established to provide the UK's ...

Scenic Biotech enters into genetic modifier collaboration with Genentech

Multi-year strategic collaboration in target discovery and therapeutic development based on Scenic Biotech’s disease ...